Introduction
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a multi-ligand scavenger receptor that was originally identified as the primary receptor for oxLDL, mediates a series of proatherogenic cellular responses implicated in the pathogenesis of atherosclerosis-related diseases [1, 2] . These diseases continue to be a major cause of morbidity and mortality in the world. LOX-1 basal expression is relatively low, and it is substantially up-regulated in multiple disease states [3] . LOX-1 expressed on the cell surface can be proteolytically cleaved and released into the circulation in a soluble form (sLOX-1). sLOX-1 has proved to be a sensitive diagnostic biomarker of vascular pathology [4] . In addition, recent evidence indicates that targeting LOX-1 is a reliable strategy for the therapy of vascular disease and that LOX-1-mediated proatherogenic effects can be inhibited by anti-LOX-1 monoclonal antibodies (MAbs) [5] . Moreover, LOX-1 can be used for plaque imaging using MAbs and selective delivery of anti-atherosclerotic agents [6] .
MAbs occupy a large portion of biopharmaceutical proteins [7] . There are mainly two disadvantages of using the MAb molecules; one is the large molecular size, which limits their penetration into diseased areas, and the other is the binding of the crystallizable fragment (Fc) domain of the MAbs to the cell surface Fc receptor, which limits their circulation and mobility [8] . As a substitute for large intact MAbs, scFvs have tremendous potential for use in diagnosis and targeted therapy because of their specific binding affinity to the antigen, their small size, superior biodistribution, and blood clearance; additionally, they can be easily engineered or modified [9, 10] . Recently, an anti-LOX-1 scFv has been developed for targeting LOX-1 [11] , which we believe has rich potential as a LOX-1 targeting vector for immunodiagnostics, drug delivery, and potential immunotherapy, that requires further research. However, the minor yield of this scFv produced using the Free Style 293 expression system limited its further engineering and application. Therefore, it is urgent to develop efficient methods for producing this scFv.
ScFv can be produced using a wide range of platforms, including production in the periplasm of prokaryotes [12] ; in the endoplasmic reticulum of eukaryotes [13] ; and in cell-free expression systems [14] . Of these expression systems, Escherichia coli is a widely used host that is suitable for expressing small non-glycosylated recombinant antibody fragments, including scFv [15, 16] . In recent years, a promising host, Brevibacillus choshinensis, was developed for antibody fragment production. Using B. choshinensis, we have successfully obtained secreted matrix metalloproteinase 26 [17] , which expressed as inclusion bodies in E. coli hosts.
In this study, the abundant expression of the anti-LOX-1 scFv was attempted using E. coli and B. choshinensis. The optimization study was performed using Plackett-Burman screening design and the response surface methodology (RSM). After that, the scFvs obtained from the two expression systems were purified using a two-step column chromatography purification progress. Finally, properties of the purified anti-LOX-1 scFv proteins were studied. As an ideal antibody for use in therapeutic purposes, it must have good pharmaceutical properties, such as antigen affinity and thermal stability. Results showed that B. choshinensis can act as an efficient host for the secreted expression of the anti-LOX-1 scFv in abundance.
Materials and Methods

Bacterial Strains, Vectors, and Media
The E. coli strains (Novagen, USA) BL21(DE3), Origami, Rosettagami 2(DE3), and Rosetta-gami 2(DE3)pLysS, and B. choshinensis SP3 (Takara, Japan) were used for scFv expression. The vector pNCMO2, a B. choshinensis-E. coli shuttle vector obtained from Takara, was used for the expression in B. choshinensis. The vectors (Novagen) pET-20b(+), pET-21a(+), pET-23a(+), and pET-27b(+) were used for expressing the scFv in E. coli.
LB medium was used to culture E. coli. B. choshinensis strains used for the expression and secretion of anti-LOX-1 scFv was respectively grown in medium 5YC (3% glucose, 3% polypeptone, 0.2% yeast extract, 0.01% MgCl 
Plasmid Construction
The anti-LOX-1 scFv was designed on the basis of sequences of the variable heavy (V with a Cterminal peptide encoding the myc (myc) epitope and a polyhistidine (6×His) metal-binding tag to facilitate the purification and immunodetection of the gene product. The gene fragment was chemically synthesized and cloned into a pUC19 vector by Beijing Genomic Institute (BGI, China), and the plasmid was named pUC19-scFv.
Plasmid pUC19-scFv was used as the template for the PCR. To append the EcoRI and SalI restriction sites for cloning into the vectors pET-21a(+) and pET-23a(+), the primer sets 5'-CGG AATTCGAAGTCAAACTGCTGGAATCTGG-3' (forward) and 5'-GCGTCGACTCATTAGTGGTGGTGATGATGGTGAGC-3' (reverse) were used. For cloning into the vectors pET-20b(+) and pET27b(+), primer sets 5'-CGGAATTCCGAAGTCAAACTGCTGGAA TCTGG-3' (forward) and the same reverse primer as mentioned above were used. For cloning into the vector pNCMO2, primer sets 5'-GCGTCGACGAAGTCAAACTGCTGGAATCTGG-3' (forward) and 5'-CGGAATTCTCATTAGTGGTGGTGATGATGGTGAGC-3' (reverse) were used. The resulting PCR products were digested with EcoRI and SalI, and then they were cloned into the vectors digested using the corresponding restriction enzymes to form the expression plasmids. These expression plasmids were correspondingly named pET21-scFv, pET23-scFv, pET20-scFv, pET27-scFv, and pNC-scFv.
Expression of the Anti-LOX-1 scFv in E. coli Hosts E. coli strain BL21(DE3), Origami, Rosetta-gami 2(DE3), and Rosetta-gami 2(DE3)pLysS were respectively transformed with the expression plasmids pET21-scFv, pET23-scFv, pET20-scFv, and pET27-scFv, and then the transformants were cultured in LB medium containing the required antibiotic(s). The culture was shaken at 37ºC until the cell density (OD 6 0 0 ) reached 0.4-0.6. Then, the induction was conducted by adding 0.5 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG). For optimization, cultivations were performed using different IPTG concentrations (0.25, 0.5, 1, or 2 mM) and temperatures (18ºC, 25ºC, 30ºC, or 37ºC). The cells were harvested by centrifugation, and the cell pellet was resuspended in 50 mM sodium phosphate buffer (PBS, pH 7.4) containing 0.2 M NaCl. For cell lysis, the cells were homogenized and disrupted by sonication. The lysates were centrifuged at 27,000 ×g for 30 min at 4ºC.
Secreted Expression of Anti-LOX-1 scFv in the B. choshinensis Host B. choshinensis SP3 cells harboring the plasmid pNC-scFv were cultured overnight at 37ºC in 2SY, BTY, LB, 5YC, B2, and/or TM medium plates containing 10 mg/l neomycin (Sigma-Aldrich, USA). Shaker-flask studies were carried out in 250 ml shaker flasks containing 100 mL of corresponding medium at 30ºC or 37ºC. The secreted proteins from each culture supernatant were collected by centrifugation at 5,400 ×g for 20 min at 4ºC and then analyzed by reducing SDS-PAGE. The gel was scanned, and the target protein expression level was analyzed densitometrically using Quantity One software (Bio-Rad Laboratories, USA).
Optimization of Culture Medium
A Plackett-Burman screening project was developed to screen the formulation variables that have an important effect on the anti-LOX-1 scFv yield. RSM was applied to optimize the key factors involved in anti-LOX-1 scFv production. Design-Expert software (ver. 8.0.6; Stat-Ease, Inc., USA) was used for the experimental design and for making RSM plots. Finally, bioreactor cultivation was performed in a 5-L fermentor containing 2 L of optimal medium. The fermentation temperature was maintained at 30ºC, and the medium pH was maintained at 7.2 by adding 2 M H 2 SO 4 and 5 M NaOH when required.
Purification of the Anti-LOX-1 scFv Proteins
The target protein, which was secreted in the medium or present in the supernatant of the centrifuged lysate, was ultrafiltered, concentrated, and loaded onto a 5 ml Ni-NTA affinity column (GE Healthcare, USA), and the column was washed with washing buffer (PBS containing 0.2 M NaCl and 25 mM imidazole, pH 7.4). The bound proteins were eluted by gradually increasing the imidazole concentration to 0.5 M. The peak fractions were pooled and immediately applied to a Hiload 26/60 Superdex 200 pg (GE Healthcare, USA). The purified scFv from E. coli was called scFv-EC, and scFv-BC was obtained from the B. choshinensis host. The protein samples of each purification step were analyzed by reducing SDS-PAGE, and the concentration was measured using the BCA Protein Assay Kit (Pierce, USA).
Affinity Analysis by Biolayer Interferometry (BLI)
Experiments were performed using the purified scFv proteins on an Octet RED96 system (ForteBio, USA) at 30ºC. For the Octet analysis, streptavidin (SA) biosensors and a kinetic buffer (50 mM PBS, containing 0.2 M NaCl, pH 7.4) were used. One milligram of human LOX-1 protein (Sino Biological Inc., China) was biotinylated at a 1:1 ratio with EZLink Sulfo-NHS-Biotin (Pierce), so that it would bind to the SA biosensor. The assays were measured in a 96-well format according to a method from a previous study [18] . Kinetic responses were fitted to a 1-site binding model to obtain the values for the kinetic association (k 
Far-UV CD Spectral Analysis
Far-UV CD spectral measurements were performed as described previously [19] . The CD spectra in the range of 200-240 nm were determined using a J-715 spectropolarimeter (Jasco, Japan) at room temperature. The purified scFv proteins at 0.5 g/l in PBS (pH 7.4) were used for CD spectral analysis. Four scans were performed at a scan rate of 10 nm/min and at a response time of 4 sec using the path-length of the cell (0.2 mm). The changes in the mean residue ellipticities at 218 nm upon increased temperatures were monitored, and the transition point was estimated.
Intrinsic Fluorescence Spectroscopy Analysis
The intrinsic fluorescence of scFv proteins was measured using a RF-5301 fluorescence spectrophotometer (Shimadzu, Japan) with a 1.0 cm quartz cuvette. The fluorescence emission spectrum of each antibody sample at the concentration of 0.1 g/l was monitored. The emission spectra, excited at the wavelength of 295 nm, in the range of 300-400 nm, were recorded. Scans were performed in triplicates, and the mean values are presented. The parameter mean I on the temperature of each scFv protein sample was determined as described previously [20] .
Dynamic Light Scattering (DLS)
The particle size of each purified scFv at 0.5 g/l in PBS containing 0.2 M NaCl (pH 7.4) was analyzed using DLS with a NANO ZS90 system (Melvin, UK). The experiments were performed at room temperature.
Results and Discussion
Expression and Purification of the Anti-LOX-1 scFv in E. coli Strains Plasmids pET21-scFv and pET23-scFv expressed an abundant amount of insoluble anti-LOX-1 scFv protein in the four E. coli strains. Plasmids pET20-scFv and pET27-scFv with a pelB signal sequence fused in front of the anti-LOX-1 scFv expressed a small fraction of soluble anti-LOX-1 scFv in both the Rosetta-gami 2(DE3) and Rosetta-gami 2(DE3)pLysS strains (data not shown). Rosetta-gami 2(DE3) containing pET20-scFv reached the highest soluble yield (2.3 mg/l) under the optimized induction conditions with 0.1 mM IPTG at 18ºC for 16 h. After induction, cell pellets from 4 L cultures were collected and underwent ultrasonic disruption. The supernatants were concentrated and subjected to Ni-NTA affinity chromatography and subsequent gel filtration chromatography for purification. At each step, the samples were analyzed by SDS-PAGE (Fig. 1A) . Although these four E. coli hosts tested here had been reported to be efficient for heterologous protein expression [21] , they do not seem to work well for expressing soluble anti-LOX-1 scFv protein. Perhaps more efficient expression of scFv proteins can be achieved using other E. coli host strains with the corresponding expression vectors; however, this requires laborious attempts. Moreover, the refolding of insoluble protein from E. coli requires extensive trial-and-error attempts [22] .
Expression and Purification of the Anti-LOX-1 scFv in B. choshinensis B. choshinensis SP3 cells were transformed with pNC-scFv or the empty vector pNCMO2 as the negative control, and cultured at 30ºC for 48 h in TM medium. The cultures were then centrifuged to separate the supernatants and cells. The samples from the total expression, supernatants, and precipitations were analyzed by SDS-PAGE (Fig. 1B) . The results showed that the anti-LOX-1 scFv proteins were expressed and existed in the culture supernatants. The expressed scFv showed an approximately 29 kDa protein band as seen using SDS-PAGE, and this is consistent with its theoretical molecular weight. It reached a yield of 125 mg/l. The supernatants from 200 ml cultures were subjected to purification, and the samples of each purification step were analyzed by SDS-PAGE (Fig. 1C) . After purification, the scFv with high electrophoretic purity was obtained. The efficient secretory expression of the scFv protein indicated that the B. choshinensis expression system could, with optimization, become a superior system to E. coli in terms of soluble production of the anti-LOX-1 scFv. B. choshinensis SP3 is a non-sporulating bacterium, lacking extracellular proteases, facilitating disulfide bond formation, and characterized by efficient secretory production, and has been successfully used for the abundant production of heterogenous proteins including antibody fragments [23] . On the other hand, the high-level expression of heterogenous proteins in E. coli hosts often leads to the formation of inclusion bodies, and the secretion efficiency is typically low if expressed using secretion signals [24] . Moreover, the gram-negative E. coli produces toxic endotoxins, whereas B. choshinensis is a gram-positive nonpathogenic bacillus, which is suitable for microbial fermentation in the pharmaceutical industry [25] .
Expression of the Anti-LOX-1 scFv in B. choshinensis Cultured in Different Media
Secreted anti-LOX-1 scFv was observed initially at 24 h in the culture media TM, BTY, 2SY, and 5YC at 30ºC ( Fig. 2A) and in all of the culture media at 37ºC (Fig. 2B) . The highest yield was reached at 60 h under 37ºC and 72 h under 30ºC for all of the culture media. A maximum yield of 200 mg/l anti-LOX-1 scFv was obtained using the condition of 30ºC, 72 h, and TM medium. The anti-LOX-1 scFv showed a higher expression level in the TM, 5YC, BTY, and 2SY media, which contained the same carbon source, glucose, but different nitrogen sources and metal ions. These chemicals were subjected to a further systematic optimization. (A) Purification of the scFv from E. coli. Each purification step samples of the suspensions (Sup), flow through (FT), wash with PBS containing 25 mM imidazole (W1) and 100 mM imidazole (W2), elution (E) from the Ni-NTA column, and peak samples (pg200) from filtration chromatography were analyzed by SDS-PAGE. (B) Expression of the scFv in B. choshinensis. The samples of the total expression of pNCMO2 (Ct) and pNC-scFv (Et), the supernatants of pNCMO2 (Cs) and pNC-scFv (Es), and the precipitations of pNCMO2 (Cp) and pNC-scFv (Ep) were analyzed by SDS-PAGE. (C) Purification of the scFv from B. choshinensis. The samples of supernatants (Sup), flow through (FT), and wash with PBS containing 25 mM imidazole (W1) and elution (E) from the Ni-NTA column as well as the peak samples (pg200) from filtration chromatography were analyzed by SDS-PAGE. Lane M: protein marker.
Plackett-Burman Screening Design and Optimization of Key Factors Using RSM
A Plackett-Burman screening design was applied to screen the 10 independent variables that have an important effect on the expression yield of anti-LOX-1 scFv. As shown in Fig. 3A , the Pareto chart revealed that glucose, beef extract, and soytone (p < 0.05) had a significant effect on the expression yield of anti-LOX-1 scFv. RSM was employed to optimize the concentrations of the three key factors. As shown in the results of the 2D contour plots (Fig. 3) , the scFv yield increased with increase of the beef extract concentration from 1.0 to 8.2 g/l and decreased in the range beef extract concentration from 8.2 to 20.0 g/l (Figs. 3B and 3D) . Additionally, the scFv yield increased as the concentration of soytone increased from 5.0 to 22.4 g/l and decreased as the concentration increased from 22.4 to 40.0 g/l (Figs. 3B and 3C ). Beef extract and soytone, which acted as nitrogen sources, can provide growth factors, amino acids, and short peptides for the growth of the host strains. During fermentation, the excess nitrogen sources were gradually decomposed and released ammonia into the medium, which can lead to the increase of the medium pH [26] . When the concentration of the beef extract and soytone increased up to 8.2 and 22.4 g/l, the nitrogen source was consumed for the growth of the host strains, which would not lead to intolerable pH changes. However, when excess nitrogen source was supplied, the medium pH increased gradually, which might seriously affect scFv production. As shown in Figs. 3C and 3D , the scFv yield increased as the glucose concentration increased in the range of 5.0 to 31.6 g/l, and nearly remained unchanged in the range from 31.6 to 40 g/l. During fermentation, glucose, acting as the carbon source, can provide energy for the growth of the host strains and the scFv expression, whereas insufficient glucose may lead to lower scFv yield. When the glucose concentration was 31.6 g/l, the carbon source was sufficient, and any more glucose did not make more improvements.
The response surface results indicated that the maximum yield of the scFv would be 355 mg/l when the concentrations of glucose, beef extract, and soytone were 31.6, 8.2, and 22.4 g/l, respectively. To verify this prediction, anti-LOX-1 scFv production was developed under the optimal conditions, and a high yield of 350 mg/l was obtained. Through the systematic optimization, the scFv yield was increased 2.8-fold compared with that obtained with the initial culture conditions. Based on the optimization results, a batch fermentation strategy was applied in a 5-L fermentor. As shown in Fig. 4 , the growth curve and anti-LOX-1 scFv expression curve were estimated, and the average maximum yield (1.5 g/l) can be reached under the optimized conditions, which is support for the industrial scale-up production of this anti-LOX-1 scFv.
LOX-1-Binding Affinity of the Purified scFv Proteins Assessed by BLI
The association and dissociation reactions of the LOX-1 antigen immobilized on a sensor chip were examined against each scFv sample as a function of the concentrations of 10, 5, 2.5, 1.25, 0.625, and 0.3125 μM. The assays were analyzed using Data Analysis 7.0, and the K D value was found to be 1.01E-07 M for the scFv produced from the B. choshinensis host (scFv-BC) and 4.53E-07 M for the scFv produced from the E. coli host (scFv-EC) (Fig. 5) . The anti-LOX-1 scFv expressed by B. choshinensis showed a similar antigen affinity to that of the Free Style 293 expression system [11] and displayed a 3.5-fold higher LOX-1-binding affinity than that of scFv-EC. A similar result was found in a previous study, where Gaciarz et al. [27] reported that the soluble scFv of Herceptin sourced from E. coli displayed incomplete folding and showed worse activity than that of B. choshinensis.
Structural Characterization of the Purified scFv Proteins Studied by Spectral Analysis
The tertiary structural properties of the scFv proteins were probed by fluorescence spectroscopy using an excitation wavelength of 295 nm. Both scFv proteins displayed a peak between 320 and 340 nm (Fig. 6A) , indicating a high order structure. Compared with scFv-EC, scFv-BC showed a 4 nm blue shift, indicating a more compact folding. The secondary structure properties of scFv-BC and scFv-EC were examined using far-UV CD spectra. The spectra (Fig. 6B ) of both scFv proteins showed a negative peak at 218 nm, consistent with the β-sheet found in immunoglobulin protein folding, whereas the whole secondary structure of scFv-EC was not fairly evident. This may indicate defects in folding. Furthermore, different from scFv-EC, the scFv-BC spectrum displayed an obvious ellipticity minimum of the negative peak at 230 nm, which was described for some V L domains [28, 29] , and is an indication of complete folding. The size and homogeneity of the scFv proteins were analyzed using DLS, which has been widely used to characterize micron-and submicron-sized particles in solution [30] . As shown in Fig. 6C , the DLS data of scFv-BC showed a monodisperse structure and one peak at 9.388 nm, suggesting a uniform distribution of monomer scFv. For scFv-EC, peaks were detected at 13.54 and >500 nm, indicating an aggregation tendency. The structural analysis proved that compared with scFv-EC, scFv-BC had a more compact folding. The secretory expression style facilitates the proper folding of proteins, especially proteins requiring disulfide bridge formation, as they must pass through a more favorable redox potential in the periplasmic space [31] , which may be conducive to the correct folding of anti-LOX-1 scFv.
Thermal Stability
Heat denaturation allows for the determination of the thermodynamic parameters of the unfolding process, using intrinsic fluorescence spectra excited at 295 nm. Changes in the value I [32] of scFv-BC and scFv-EC at temperatures from 25ºC to 65ºC were determined. The I values of scFv-BC and scFv-EC both decreased slightly as the temperature increased from 25ºC to 50ºC, suggesting that the fluorophores of the two scFv proteins had become more water-accessible during heating. The main transition occurred in the temperature range of 52-56ºC with a midpoint temperature of transition (T m ) value of 55.9 ± 0.2ºC for scFv-BC, and 48-58ºC with a T m value of 53.2 ± 0.3ºC for scFv-EC (Fig. 7A) . As the two anti-LOX-1 scFv samples are both mainly β-sheets with a typical 218 nm minimum ellipticity, the temperature-induced changes in ellipticity at 218 nm allowed us to evaluate the structural changes of the scFv samples under increased temperatures from 40ºC to 65ºC. The T m value was 54.5 ± 0.4ºC for scFv-BC and 51.7 ± 0.2ºC for scFv-EC (Fig. 7B) . The average T m value measured by the two methods was 52.5 ± 0.3ºC for scFv-EC and 55.2 ± 0.3ºC for scFv-BC. These results revealed that scFv-BC displayed better thermal stability, which will support its further medical application.
In conclusion, we reported that the anti-LOX-1 scFv had limited soluble expression in E. coli but can be efficiently secreted by B. choshinensis. After optimization using Plackett-Burman screening design and RSM, the secreted scFv yield can reach 350 mg/l in a shaker flask and 1.5 g/l in a 5-L fermentor. Moreover, the properties of the scFv proteins obtained from the two expression systems were different. The antigen affinity, transition temperature, and particle diameter size were 1.01E-07 M, 55.2 ± 0.3ºC, and 9.388 nm for the scFv expressed by B. choshinensis host, and 4.53E-07 M, 52.5 ± 0.3ºC, and 13.54 nm for the scFv expressed by E. coli host. B. choshinensis proved to be an ideal host for efficient expression of the anti-LOX-1 scFv. This study lays a foundation for the scale-up production of anti-LOX-1 scFv, which will boost the utility of the scFv in further engineering and applications in the diagnosis and therapy of atherosclerotic-related diseases. 
